Oaktree Acquisition Corp. III Life Sciences (OACC) Operating Income (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Operating Income of -$456538.0 for Q1 2026, down 2.64% on a YoY basis from -$468910.1 in Q1 2025, and down 78.69% quarter-over-quarter from -$255496.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Operating Income (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Operating Income for 2 years, with the latest figure at -$456538.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Income fell 2.64% year-over-year to -$456538.0; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (changed N/A YoY), and the FY2025 full-year result was -$1.2 million, down 239.87% from the prior year.
  • Operating Income for Q1 2026 stood at -$456538.0, down from -$255496.0 in the prior quarter.
  • The five-year high for Operating Income was -$225579.0 in Q3 2025, with the low at -$456538.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -427,850.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - -482,100.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -201,744.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -84,204.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -1.15 Mn
6 WEN Acquisition 309.15 Mn 309.15 Mn - -225,545.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - -198,194.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 685,558.00
9 BTC Development 262.16 Mn 262.16 Mn - -540,761.00
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - -456,538.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -456,538.00
Dec 31, 2025 -255,496.00
Sep 30, 2025 -225,579.00
Jun 30, 2025 -269,810.00
Mar 31, 2025 -444,802.00